Can sibutramine alter systemic blood pressure in obese patients? Systematic review and meta-analysis

Volume: 126, Issue: 6, Pages: 342 - 346
Published: Nov 1, 2008
Abstract
CONTEXT: Systemic arterial hypertension is part of the metabolic syndrome resulting from obesity. OBJECTIVE: To evaluate the effect of sibutramine on overweight and obese patients' blood pressure through a systematic review. METHODS: All the studies included needed to be randomized controlled trials. The methodological quality of the selected trials was assessed using the criteria described in the Cochrane Handbook. The participants were...
Paper Details
Title
Can sibutramine alter systemic blood pressure in obese patients? Systematic review and meta-analysis
Published Date
Nov 1, 2008
Volume
126
Issue
6
Pages
342 - 346
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.